Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.7 |
mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |